NHS England Drug Tariff Part IX Wound Care Products RFI

NHS England is undertaking a review of the current processes and commercial models which support the prescribing and supply of wound products listed in Part IX of the Drug Tariff. This review is guided by the National Wound Care Strategy Programme recommendations to address unwarranted variation, improve consistency, and ensure the best possible outcomes for patients and value for the NHS. As part of this review, we are seeking feedback and information on current arrangements to help inform the future strategy. The...